Are you Dr. Stanford?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 64 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
244 5th Ave
# 9B
New York, NY 10001Phone+1 212-684-3780
Summary
- Dr. Arielle Stanford, MD is a board certified psychiatrist in New York, New York. She is currently licensed to practice medicine in New York and Massachusetts.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1999 - 2003
Washington University in St. Louis School of MedicineClass of 1999
Certifications & Licensure
NY State Medical License 2000 - 2026
MA State Medical License 2011 - 2016- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) Start of enrollment: 2004 Sep 01
Publications & Presentations
PubMed
- 1 citationsEnsuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group.Gahan J Pandina, Joan Busner, Lucas Kempf, Joan Fallon, Larry D Alphs
Innovations in Clinical Neuroscience. 2024-03-01 - 11 citationsReduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.Christoph U Correll, Evan Stein, Christine Graham, Lauren DiPetrillo, Sarah Akerman
Schizophrenia Bulletin. 2023-03-15 - 10 citationsRespiratory-gated auricular vagal afferent nerve stimulation (RAVANS) modulates brain response to stress in major depression.Ronald G. Garcia, Justine E. Cohen, Arielle D. Stanford, Aileen Gabriel, Jessica Stowell
Journal of Psychiatric Research. 2021-10-01
Authored Content
- S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
- S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
Grant Support
- Negative Symptoms Of Schizophrenia: From Phenomenology To Targeted TreatmentNational Institute Of Mental Health2011
- Negative Symptoms Of Schizophrenia: From Phenomenology To Targeted TreatmentNational Institute Of Mental Health2007–2011
